成功的心脏再同步治疗减少了异步心力衰竭患者特定模型的负 septal 工作
Amanda Craine1, Adarsh Krishnamurthy1,2, Christopher T Villongco1
1Department of Bioengineering, University of California San Diego, La Jolla, California, United States of America.
PLoS computational biology
|October 10, 2024
概括
心脏再同步治疗 (CRT) 通过增加早期激活区域的心肌工作来改善异步心力衰竭 (DHF) 的心脏功能. 这促进了逆心室重塑,提高了患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 生物医学工程 生物医学工程
- 计算生物学 计算生物学
背景情况:
- 不同步心力衰竭 (DHF) 涉及由于导电异常而导致心肌不均的工作.
- 心脏再同步治疗 (CRT) 通过增强心室同步,降低发病率和死亡率来改善心脏再同步治疗.
- 直接测量心肌区域工作 (壁应力) 在患者中是不可行的.
研究的目的:
- 通过使用计算建模来研究区域心肌工作分布和CRT后的变化.
- 评估精简计算方法的临床可翻译性,以估计区域心肌工作.
- 确定CRT促进逆心室重塑的机制.
主要方法:
- 利用了三维,多尺度,患者特定的计算模型.
- 整合了接受CRT的八名心力衰竭患者的解剖学,功能,血液动力学和电生理学数据.
- 使用简化方法估计通过心室压力和内心表面积变化区域心肌工作的验证结果.
主要成果:
- CRT提高了整体心肌工作效率,使非响应者受益.
- 逆心室重塑在基线高区域性工作异质性患者中最大.
- 早期激活区域中心肌负面工作的减少最好与反向重塑相关,而不是整体工作异质性的减少.
结论:
- 通过增强早期激活区域的心肌工作,解决低 perfusion 和改变的代谢活动,CRT促进逆心室重塑在DHF.
- 精简的计算方法可以准确地估计区域心肌工作及其在CRT后的变化.
- 这些发现提供了关于CRT改善心室重塑的机制的见解.
相关概念视频
01:30Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
01:22Heart Failure VI: Adjunct Therapies
5
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
5
01:29Cardiomyopathy V: Interprofessional Care
2
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
1
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
01:25Dysrhythmias VII: Nursing Management of Dysrhythmias
3
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
3
01:25Dysrhythmias VI: Management of Dysrhythmias
3
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
3